跳至主要内容
临床试验/ACTRN12614000361606
ACTRN12614000361606已完成未知

Response of Patients with COPD to Hyperoxia and Normoxia, as Measured by Carbon Dioxide Levels.

Medical Research Institute of New Zealand0 个研究点目标入组 24 人开始时间: 2014年4月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • COPD, as diagnosed by a doctor.

排除标准

  • 1. Baseline transcutaneous carbon dioxide of greater than or equal to 60mmHg
  • 2. FEV1:FVC ratio >0.7
  • 3. Age under 16 years
  • 4. A diagnosis of bronchiectasis
  • 5. Morbid obesity (with a body mass index of greater than or equal to 40)
  • 6. Inability to match FEV1 percentage predicted to a participant that took part in the bronchiectasis oxygen study*
  • 7. Any other condition which, at the investigator’s discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.
  • *This study is designed to allow for comparison of results to a study of similar design in patients with bronchiectasis (ACTRN12612000356864). Participants will therefore be matched by FEV1 to the participants in the bronchiectasis study (the COPD participant must have an FEV1 percentage predicted within an absolute value of 5% of the FEV1 percentage predicted for the bronchiectasis patient (values inclusive)).

研究者

相似试验